See cancer.
Remove cancer.

On Target Laboratories’s fluorescent imaging technology illuminates cancer during surgery, potentially enabling surgeons to see and remove more diseased tissue.

ON TARGET technology has the potential to give skilled surgeons added intraoperative visibility which may increase the likelihood of a more complete resection. ON TARGET technology has the potential to give skilled surgeons added intraoperative visibility which may increase the likelihood of a more complete resection.

Surgeons step into the OR with a variety of pre-operative inputs that help locate tumors and suspicious lesions — but finding small lesions can still be challenging.

By targeting and illuminating cancerous tissue during a procedure, On Target’s technology has the potential to give skilled surgeons the added benefit of intraoperative sight. This added visibility may increase the likelihood of a more complete surgical resection. Complete resections are associated with reduced re-operations or adjuvant treatments1, and for patients translate into increased survival.

Increase in Survival After Complete Resection

In Lung Cancer

Complete resections are associated with reduced adjuvant treatment, and for patients translate into increased survival.
1.75X

Greater 5-Year
Survival Rates2

In Ovarian Cancer

Complete resections are associated with reduced adjuvant treatment, and for patients translate into increased survival.
1.75-3X

Greater Median
5-Year Survival3

FOOTNOTES

1 Riquet, Mark, et al. Microscopic Residual Disease After Resection for Lung Cancer: A Multifaceted but Poor Factor of Prognosis. Ann Thorac Surg. 2010;89: 870-6. doi:10.1016/j.athoracsur.2009.12.037

2 Osarogiagbon RU, Lin CC, Smeltzer MP, Jemal A. Prevalence, Prognostic Implications and Survival Modulators of Incompletely Resected Non-small-cell Lung Cancer in the US National Cancer Data Base. Journal of Thoracic Oncology. 2016;11: e5-16. doi: 10.1016/j.jtho.2015.08.002.

3 Roche KL, Gardner GJ. State of the Science: Evolving Role of Surgery for the Treatment of Ovarian Cancer. Gynecologic Oncology. 2019;155(1): pp 3-7.

On Target’s technology gives surgeons intraoperative visibility of cancerous tissue, potentially increasing the chance for a complete surgical resection.

Read the Science

Brand Strategy By Assembly
Developed By Alchemy + Aim